NORDIC EXECUTIVE MEDICINE 2020-03-16 – UPDATE ON COVID19 AND WHAT CAN BE DONE TO SUPPORT PROMISING RESEARCH

//NORDIC EXECUTIVE MEDICINE 2020-03-16 – UPDATE ON COVID19 AND WHAT CAN BE DONE TO SUPPORT PROMISING RESEARCH

NORDIC EXECUTIVE MEDICINE 2020-03-16 – UPDATE ON COVID19 AND WHAT CAN BE DONE TO SUPPORT PROMISING RESEARCH

[et_pb_section fb_built=”1″ _builder_version=”4.4.0″ hover_enabled=”0″][et_pb_row _builder_version=”4.4.0″ hover_enabled=”0″][et_pb_column type=”4_4″ _builder_version=”4.4.0″][et_pb_image src=”https://www.nordicem.se/wp-content/uploads/2020/03/image-2-300×169.png” _builder_version=”4.4.0″ hover_enabled=”0″ align=”center” custom_padding=”0px||41px||false|false” border_width_all=”4px” border_color_all=”#23588b”][/et_pb_image][et_pb_text _builder_version=”4.4.0″ text_text_color=”#000000″ text_font_size=”17px” text_letter_spacing=”1px” header_font=”||on|on|||||” header_text_color=”#000000″ hover_enabled=”0″]

Authors: Dr. Mahir Vazda & Dr. Joseph Said

At Nordic Executive Medicine (NEM), our current body of knowledge concerning SARS-CoV2/COVID19 is updated on a daily basis. The prevailing view seems to be that the virus binds to the ACE2-receptor, a cell surface protein found in the kidneys, on blood vessels, in the heart and lungs, which explains the varying symptomatology in affected individuals. The virus also affects the oxygen-carrying molecules of erythrocytes, and persons with cardiovascular disease, diabetes, and hypertension have an increased risk of developing severe complications.

Diabetics seem especially afflicted in a more significant occurrence since the glycosylation of
erythrocytes weakens the integrity of the immune system, and the body ́s natural defense mechanisms. If you are at an increased risk, it’s essential that you take all necessary preventive and protective measurements, in order to avoid contagion.

A lot of things are currently happening around the world, and we would like to take this moment to highlight promising research that is currently in need of more funding.

SARS-CoV2 (COVID19) shows several similarities with SARS-CoV, the viral strain of coronavirus that caused the SARS epidemic in China, in the early 2000s. Their genetic material shares an 80% similarity, and physicians at the Baylor College of Medicine in the U.S. are currently looking into the possibility of quickly developing a vaccine by repurposing the lead candidate for the vaccine that was in development during the SARS epidemic.

This vital research is led by Dr. Peter Hotez, M.D. Ph.D., and his research team is in great need of our support. Nordic Executive Medicine is currently looking to establish contact to see how we can help. For direct contributions, please contact [email protected] and to hear more about this subject, we highly recommend listening to this podcast https://peterattiamd.com/peterhotez/

About Nordic Executive Medicine (NEM)
NEM has extensive experience in working with preventive and occupational healthcare
services. We help our customers to create safe work environments for their employees on a
daily basis. Through our precision medicine program, we are committed to achieving
outstanding results, and we have dedicated medical resources to help employers, as part of our
program.

Our staff here at Nordic Executive Medicine has seen an increased demand for our medical
services in the recent outbreak of COVID19. We have been working around the clock in
order to provide our clients with custom-made Business Continuity Plans (BCPs) that
mitigate the risk to their business and coworkers.

Are you interested in hearing more about NEM?
Send us an inquiry, and we will contact you as soon as possible.

[/et_pb_text][/et_pb_column][/et_pb_row][/et_pb_section]

By | 2020-03-16T21:23:50+00:00 March 16th, 2020|Uncategorized|0 Comments

About the Author:

Leave A Comment